Clinical Trial Update: The Effect of a Probiotic on Protection Against Upper Respiratory Tract Infections in Children [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating whether a probiotic can protect children from upper respiratory tract infections has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Upper Respiratory Tract Infection

Drugs mentioned

• Probiotic product

Snippet

Sponsor: Probi AB | Conditions: Upper Respiratory Tract Infection | Phase 2 | Status: TERMINATED